Page last updated: 2024-08-22

pimozide and Condition, Preneoplastic

pimozide has been researched along with Condition, Preneoplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bu, W; Camacho, L; Garcia, S; Hein, S; Hilsenbeck, SG; Johnston, AN; Kapali, J; Li, Y; Nagi, C; Nangia, J; Podsypanina, K; Qin, L; Xue, L	1

Other Studies

1 other study(ies) available for pimozide and Condition, Preneoplastic

Article	Year
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast cancer research : BCR, 2018, 05-19, Volume: 20, Issue:1 Topics: Animals; Antipsychotic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Differentiation; Female; Humans; Hyperprolactinemia; Janus Kinase 2; Mice; Pimozide; Precancerous Conditions; Risk Factors; Risperidone; Signal Transduction; STAT5 Transcription Factor	2018

Article

Year

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.

Breast cancer research : BCR, 2018, 05-19, Volume: 20, Issue:1

Topics: Animals; Antipsychotic Agents; Apoptosis; Breast; Breast Neoplasms; Cell Differentiation; Female; Humans; Hyperprolactinemia; Janus Kinase 2; Mice; Pimozide; Precancerous Conditions; Risk Factors; Risperidone; Signal Transduction; STAT5 Transcription Factor

2018